Planetary Health Diet, Socioeconomic Inequalities, and Chronic Kidney Disease and Mortality Risk [0.03%]
planetary health饮食、社会经济不平等和慢性肾病及死亡风险
Shaohui Liu,Qiyini Ma,Li&#x;e Zhang et al.
Shaohui Liu et al.
Background: While planetary health diet (PHD) benefits human and environmental health, its impact on chronic kidney diseases (CKD) under socioeconomic deprivation remains unclear. We investigated the associations between ...
The New American Board of Internal Medicine Special Consideration Pilot: Impact on Nephrology and its international medical graduates [0.03%]
美国内科医学会新董事会特殊考虑试点项目的影响：内科学和国际医学毕业生的情况分析
Jeffrey S Berns,Koyal Jain,Molly Rubin et al.
Jeffrey S Berns et al.
Computed Tomography Instrumentation and Myosteatosis Thresholds as Explanations for the Different Impact of Myosteatosis across Kidney Transplant Recipient Populations [0.03%]
CT设备的差异和肌肉脂肪浸润的阈值可能是肾移植受者中肌肉脂肪浸润影响不同的原因
Thomas Stehlé,Antoine Morel,Michael Moryoussef et al.
Thomas Stehlé et al.
Author Response to Computed Tomography Instrumentation and Myosteatosis Thresholds as Explanations for the Different Impact of Myosteatosis across Kidney Transplant Recipient Populations [0.03%]
作者对CT仪器和肌内脂肪阈值的回复，解释了肌内脂肪在不同肾移植受者人群中的不同影响原因
Marcel Zorgdrager,Mara McAdams DeMarco,Robert A Pol
Marcel Zorgdrager
Estimating and Interpreting Total Estimated Glomerular Filtration Rate Slope via Mixed Models [0.03%]
基于混合模型估计和解释总估算肾小球滤过率斜率
Maria E Montez-Rath,June Li,Tianyu Pan et al.
Maria E Montez-Rath et al.
Kidney and Survival Outcomes with Semaglutide by Chronic Kidney Disease Severity in the FLOW Trial [0.03%]
FLOW试验中根据慢性肾脏病严重程度评估司美格鲁肽对肾脏和生存结果的影响
Katherine R Tuttle,Johannes F E Mann,Manuel M Mayrdorfer et al.
Katherine R Tuttle et al.
Background: Semaglutide improved kidney and overall survival in participants with type 2 diabetes (T2D) and chronic kidney disease (CKD) in the FLOW trial. The aim of the present analyses was to quantify these benefits ac...
Rasmus Rørth,Milos M Koch,Thomas A Gerds et al.
Rasmus Rørth et al.
Background: Impaired kidney function is associated with mortality, cardiovascular events, and hospitalization as well as diminished functional capacity and health-related quality of life. We hypothesized that kidney funct...
Obesity in Living Kidney Donors From Risk to Ethics: Bridging Gaps in Evaluation and Management [0.03%]
肥胖供肾者：从风险到伦理：评估和管理中的缺口与对策
Pooja Budhiraja,Beata Bzoma,Aleksandar Denic et al.
Pooja Budhiraja et al.
Obesity is increasingly prevalent among living kidney donor (LKD) candidates, presenting complex clinical, ethical, and logistical challenges. Although obesity is linked to increased post-donation hypertension, diabetes, proteinuria, and ch...
Effectiveness of Multicomponent Interventions in Slowing Progression of Chronic Kidney Disease Stages G3-G4: A Systematic Review and Meta-Analysis [0.03%]
多组分干预减缓慢性肾脏病3~4期进展的系统评价和meta分析
Chenxinan Ma,Lei Wu,Yaxi Li et al.
Chenxinan Ma et al.
Background: Various multicomponent interventions (MCIs) have been increasingly used for managing patients with chronic kidney disease (CKD) G3-G4, but they have not been systematically evaluated for the collective evidenc...
NIH Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials [0.03%]
NIH研讨会：通过优化肾脏精准医学临床试验加速药物创新
Melanie S Joy,Rasheed A Gbadegesin,Paul T Conway et al.
Melanie S Joy et al.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsored a scientific workshop in 2024, titled "Preparing for Kidney Precision Medicine Clinical Trials." The purpose of the workshop was to gain a better underst...